Exercise Training and Testosterone Replacement in Heart Failure Patients
NCT ID: NCT01852994
Last Updated: 2016-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
39 participants
INTERVENTIONAL
2009-07-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* hospital length of stay and readmission
* muscle sympathetic nerve activity
* functional capacity
* body composition
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise training
Aerobic and strength exercise training
Exercise training
Aerobic and strength exercise training
Testosterone replacement
Testosterone replacement will be done quarterly
Testosterone replacement
Application quarterly of Testosterone Undecylate
Testosterone replacement+Exercise
Both Testosterone replacement and Exercise will done
Testosterone replacement
Application quarterly of Testosterone Undecylate
Exercise training
Aerobic and strength exercise training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Testosterone replacement
Application quarterly of Testosterone Undecylate
Exercise training
Aerobic and strength exercise training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hypogonadism
* left ventricular fraction ejection \< 45%
Exclusion Criteria
* normal testosterone
* pace maker
18 Years
65 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Janieire N Alves, MD; PhD
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto do Coração do Hospital da Clínicas da Universidade de Sao Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Testosterone
Identifier Type: -
Identifier Source: org_study_id